Silvercrest Asset Management Group LLC Rhythm Pharmaceuticals, Inc. Transaction History
Silvercrest Asset Management Group LLC
- $14.7 Billion
- Q3 2025
A detailed history of Silvercrest Asset Management Group LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 34,084 shares of RYTM stock, worth $3.39 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
34,084
Previous 48,775
30.12%
Holding current value
$3.39 Million
Previous $3.08 Million
11.68%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding RYTM
# of Institutions
281Shares Held
485MCall Options Held
498KPut Options Held
150K-
Perceptive Advisors LLC New York, NY419MShares$41.7 Billion94.44% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$670 Million0.01% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.68MShares$565 Million9.85% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$557 Million4.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA5MShares$497 Million0.01% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $5.54B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...